Therapeutic Target-Humanized Mice
Cre/Dre-Driver Mice
Immunodeficient NMG Mice
Strain Name：OCI-LY3 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-B34
Human B cell lymphoma cell line
Strain Name：Hep-2 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-Y06
Human laryngeal epidermal carcinoma cell line
Strain Name：MC38-Tnfrsf1bem1(hTNFR2)Smoc Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NMC-230001
TNFRSF1B gene humanized MC38 cell line
Strain Name：CT26-hCD133 Strain State ： Validation of target gene expression completed | Cat. NO.：NM-S24A-TM14
CD133 gene humanized CT26 cell line
Strain Name：B16F10-hCD47/Sirpa Strain State ： Construction | Cat. NO.：NMC-230058
CD47 gene humanized B16F10 cell line with Sirpa gene overexpression
Strain Name：MOLM-13 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-B28
Human acute lymphoblastic leukemia cell line
Strain Name：OCI-AML-3 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-B33
Human acute myelogenous leukemia cell line
Strain Name：MOLT-4 Strain State ： Validation of tumorigenic capacity | Cat. NO.：NM-B12
Strain Name：Hepa1-6-Luc Strain State ： Validation of tumorigenic capacity completed | Cat. NO.：NM-GA02-1
Luciferase-labeled Hepa1-6 cell line
Strain Name：MC38-Tg(hENPP3)Smoc Strain State ： Validation of target gene expression completed | Cat. NO.：NMC-230023
ENPP4 gene humanized MC38 cell line
Please fill in the order form and we will contact you within 2 working days.
